Posted by Michael Wonder on 18 Sep 2023
Orexo submits new drug application to FDA for OX124, a high-dose rescue medication for opioid overdose
18 September 2023 - OX124 is based on Orexo´s world-class drug delivery platform amorphOX and is designed to reverse the effect of the most powerful synthetic opioids, such as fentanyl.
Orexo today announces the submission of the new drug application to the US FDA for OX124, a high-dose rescue medication for opioid overdose with nasal delivery.
